Long-Term Outcomes in Chronic Lymphocytic Leukemia Treated with Ibrutinib: 10-Year Follow-up of a Phase 2 Study

Category Primary study
JournalBlood
Year 2023
This article has no abstract
Epistemonikos ID: 7547f6548353cdaccba40280202dcab0be5b9715
First added on: Feb 17, 2025